  Electronic Health Record (EHR) has emerged as a valuable source of data for
translational research. To leverage EHR data for risk prediction and
subsequently clinical decision support, clinical endpoints are often time to
onset of a clinical condition of interest. Precise information on clinical
event times is often not directly available and requires labor-intensive manual
chart review to ascertain. In addition, events may occur outside of the
hospital system, resulting in both left and right censoring often termed double
censoring. On the other hand, proxies such as time to the first diagnostic code
are readily available yet with varying degrees of accuracy. Using error-prone
event times derived from these proxies can lead to biased risk estimates while
only relying on manually annotated event times, which are typically only
available for a small subset of patients, can lead to high variability. This
signifies the need for semi-supervised estimation methods that can efficiently
combine information from both the small subset of labeled observations and a
large size of surrogate proxies. While semi-supervised estimation methods have
been recently developed for binary and right-censored data, no methods
currently exist in the presence of double censoring. This paper fills the gap
by developing a robust and efficient Semi-supervised Estimation of Event rate
with Doubly-censored Survival data (SEEDS) by leveraging a small set of gold
standard labels and a large set of surrogate features. Under regularity
conditions, we demonstrate that the proposed SEEDS estimator is consistent and
asymptotically normal. Simulation results illustrate that SEEDS performs well
in finite samples and can be substantially more efficient compared to the
supervised counterpart. We apply the SEEDS to estimate the age-specific
survival rate of type 2 diabetes using EHR data from Mass General Brigham.
